Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice.
Feng Y, Gordts SC, Chen F, Hu Y, Van Craeyveld E, Jacobs F, Carlier V, Feng Y, Zhang Z, Xu Q, Ni Y, De Geest B.
Feng Y, et al.
Atherosclerosis. 2011 Feb;214(2):271-8. doi: 10.1016/j.atherosclerosis.2010.09.024. Epub 2010 Sep 29.
Atherosclerosis. 2011.
PMID: 20943224